Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 33 % of short-term debt in 2025; threshold 65 %.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
BanChiMed from Enghien, company number BE0506720971, closed financial year 2025 with a result of € 118,882 after tax. For that financial year BanChiMed recorded a gross margin of € 180,736 and equity of € 2,500. Compared with financial year 2024, the result moved from € 104,911 to € 118,882. Profitable, and profit is growing. The buffer shrank hard: equity is 98 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on March 31, 2026.
€ 2,500
▼ 98% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 118,882
▲ 13% vs 2024
Profit after tax over the fiscal year.
€ 62,490
▲ 35% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 239,843 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 37,467
▼ 25% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 45,096
▼ 21% vs 2024
€ 20,349 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 2,275
▼ 51% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 11,922
▼ 36% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 129,428 | € 142,620 | € 158,853 | € 180,736 | ▲ 14% |
| Profit after taxes | € 97,323 | € 99,613 | € 104,911 | € 118,882 | ▲ 13% |
| Equity | € 23,776 | € 18,550 | € 123,461 | € 2,500 | ▼ 98% |
| Total debts | € 99,047 | € 174,266 | € 85,101 | € 252,038 | ▲ 196% |
| Cash | € 23,434 | € 27,940 | € 46,350 | € 62,490 | ▲ 35% |
| Retained profit | € 21,276 | € 16,050 | € 120,961 | € 0 | ▼ 100% |
| Dividend | € 97,323 | € 104,839 | € 0 | € 239,843 | |
| Bank debt | € 38,707 | € 84,684 | € 57,295 | € 45,096 | ▼ 21% |
| Balance sheet total | € 122,823 | € 192,816 | € 208,562 | € 254,538 | ▲ 22% |
Key figures of BanChiMed, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to BanChiMed?
What happened at BanChiMed in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 118,882 (▲ 13% vs 2024). Source: NBB ↗
- New establishment in Enghien. KBO
- Start of the company according to the CBE. KBO
In short
From € 97,323 profit in 2022 to € 118,882 profit in 2025.
Paid € 138,353 in corporate taxes since 2022.
Best year ever: 2025, with € 118,882 profit.
Paid out € 442,005 in dividends to the owners in total.
Management
Behind BanChiMed are Mugol CHIMANUKA and Mwana BANDEKELA KAZADI .
Directors
According to the 2025 annual accounts
Mugol CHIMANUKA
Director
Mwana BANDEKELA KAZADI
Director
Establishments
Establishment units
Physical locations of this company
Distelvinkendreef(P.E.) 23
7850 Enghien
Aatsesteenweg 301 box 6
7850 Enghien
Active since 10 December 2014
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0506.720.971
- VAT number
- BE 0506.720.971
- Registered office
- Distelvinkendreef(P.E.) 23, 7850 Enghien
- Names & denominations
- BanChiMed
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 10 December 2014
- Peppol
- Not registered